Michel de Rosen

Mr. Michel de Rosen, of French nationality, is Chairman of the Board of Directors of Faurecia since May 30, 2017 and member of the Governance, Nominations and Sustainability Committee. He joined Faurecia’s Board of Directors on May 27, 2016 as an independent director.

He is a graduate of the École des Hautes Études Commerciales (HEC) and the École Nationale d’Administration (ENA).

Over the course of his career, he has successively held positions first as a senior public official and then as a senior executive at companies in France and the United States.

He began his career at the Inspectorate General of Finance (IGF). He was an advisor to the French Minister

of Defense between 1980 and 1981 and served as Chief of Staff for the French Minister for Industry and Telecommunications from 1986 to 1988.

Within the Rhône-Poulenc group, he served as Chief Executive Officer of Pharmuka from 1983 to 1986 and of Rhône Poulenc Fibres et Polymères from 1988 to 1993, after which he was Chief Executive Officer and then Chairman and Chief Executive Officer of Rhône Poulenc Rorer in the United States and in France and of Rhône Poulenc Santé from 1993 to 1999. In 2000, Mr. Michel de Rosen was named Chairman and Chief Executive Officer of the US company ViroPharma. He became Chairman and Chief Executive Officer of SGD in 2008.

In 2009, he joined Eutelsat and was appointed as Deputy Chief Executive Officer on July 1, 2009 and then as Chief Executive Officer and Board member on November 9 of the same year. From September 2013 to February 2016, he was Chairman and Chief Executive Officer. From March 1, 2016 to November 8, 2017, Mr. Michel de Rosen was the Chairman of the Board of Directors.